Lung Cancer Screening in Patients with COPD-A Case Report
- PMID: 31336732
- PMCID: PMC6681240
- DOI: 10.3390/medicina55070364
Lung Cancer Screening in Patients with COPD-A Case Report
Abstract
We present two cases demonstrating the nuances that must be considered when determining if a patient could benefit from low dose computed tomography (LDCT) lung cancer screening. Our case report discusses the available literature, where it exists, on lung cancer screening with special attention to the impact of chronic obstructive pulmonary disease (COPD), and poor functional status. Patients with COPD and concurrent smoking history are at higher risk of lung cancer and may therefore benefit from lung cancer screening. However, this population is at increased risk for complications related to biopsies and lobar resections. Appropriate interventions other than surgical resection exist for COPD patients with poor pulmonary reserve. Risks and benefits of lung cancer screening are unique to each patient and require shared decision-making.
Keywords: COPD; low dose computed tomography; lung cancer screening; lung nodule.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.Cancer. 2015 May 15;121(10):1556-62. doi: 10.1002/cncr.29225. Epub 2015 Feb 3. Cancer. 2015. PMID: 25652107 Free PMC article.
-
Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial.Chest. 2019 Nov;156(5):965-971. doi: 10.1016/j.chest.2019.06.016. Epub 2019 Jul 5. Chest. 2019. PMID: 31283920 Clinical Trial.
-
Comparison of two lung cancer screening scores among patients with chronic obstructive pulmonary disease: A community study.Clin Respir J. 2019 Feb;13(2):114-119. doi: 10.1111/crj.12988. Clin Respir J. 2019. PMID: 30597746
-
The potential impact of chronic obstructive pulmonary disease in lung cancer screening: implications for the screening clinic.Expert Rev Respir Med. 2019 Aug;13(8):699-707. doi: 10.1080/17476348.2019.1638766. Epub 2019 Jul 5. Expert Rev Respir Med. 2019. PMID: 31274043 Review.
-
Benefits and Challenges of Lung Cancer Screening in Older Adults.Clin Ther. 2018 Apr;40(4):526-534. doi: 10.1016/j.clinthera.2018.03.003. Epub 2018 Mar 21. Clin Ther. 2018. PMID: 29573852 Review.
Cited by
-
Enhancing COPD classification using combined quantitative computed tomography and texture-based radiomics: a CanCOLD cohort study.ERJ Open Res. 2024 Jul 22;10(4):00968-2023. doi: 10.1183/23120541.00968-2023. eCollection 2024 Jul. ERJ Open Res. 2024. PMID: 39040582 Free PMC article.
-
Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians.Chronic Obstr Pulm Dis. 2022 Jul 29;9(3):454-476. doi: 10.15326/jcopdf.2022.0296. Chronic Obstr Pulm Dis. 2022. PMID: 35790131 Free PMC article.
References
-
- National Lung Screening Trial Research Team. Aberle D.R., Adams A.M., Berg C.D., Black W.C., Clapp J.D., Fagerstrom R.M., Gareen I.F., Gatsonis C., Marcus P.M., et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N. Engl. J. Med. 2011;365:395–409. doi: 10.1056/NEJMoa1102873. - DOI - PMC - PubMed
-
- Patz E.F., Pinsky P., Gatsonis C., Sicks J.D., Kramer B.S., Tammemägi M.C., Chiles C., Black W.C., Aberle D.R., NLST Overdiagnosis Manuscript Writing Team Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer. JAMA Intern. Med. 2014;174:269–274. doi: 10.1001/jamainternmed.2013.12738. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical